Published in Cardiovascular Business Week, July 5th, 2005
In total, five patients have now received CorAide LVAS implants since the clinical trial of the device was resumed in February 2005.
The Diabetes and Heart Center in Bad Oeynhausen, Germany has now implanted four CorAide LVAS devices. Physicians at the Center reported that the device is performing well and allowing patients to recover rapidly from the operative procedure and begin ambulation. The first two CorAide patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.